Your Location：
Home >
Browse articles >
Pathogenesis Evolution of Atherosclerosis Induced by Novel Turbid-toxin Microplastics from Perspective of "Body Fluids and Blood Stasis Mixing"
Updated：2026-05-29
Previous|Next

    • Pathogenesis Evolution of Atherosclerosis Induced by Novel Turbid-toxin Microplastics from Perspective of "Body Fluids and Blood Stasis Mixing"

    • GUO He , YANG Ying , ZHENG Yi , CHEN Zhichao , ZHANG Huan , ZHANG Ying
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 13, Pages: 253-260(2026)

    • DOI： 10.13422/j.cnki.syfjx.20260414     

      CLC：

    • Revised：2026-03-20 ，

      Accepted：20 March 2026 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

64

Views

60

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
Effect and Molecular Mechanisms of Danlou Tablet on Hepatic Lipid Deposition in ApoE-/- Atherosclerotic Mice Through Regulation of SIRT6/CREB/Nor1 Signaling Pathway-mediated Autophagy
Mechanism of Danlou Tablets in Ameliorating Hepatic Lipid Deposition by Regulating circCRIM1/miR-342-3p/SOX6-mediated Fatty Acid Synthesis

Related Author

WANG Maohong
XIONG Jianhua
ZHANG Hao
YAN Xiaohong
WAN Qiang
XIANG Jiao
LUO Jieying
LIAO Daiyuan

Related Institution

Jiangxi University of Chinese Medicine
The Affiliated Hospital of Jiangxi University of Chinese Medicine
School of Chinese Materia Medica，Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory， Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.